Do contact precautions cause depression? A two-year study at a tertiary care medical centre

Journal of Hospital Infection

Volumn 79, Issue 2, 2011, Pages 103-107

  Day, H R ^a   Perencevich, E N ^b,c   Harris, A D ^a,d   Himelhoch, S S ^a   Brown, C H ^a   Gruber Baldini, A L ^a   Dotter, E ^a   Morgan, D J ^a,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Anxiety; Contact precautions; Depression; Isolation

Indexed keywords

AMFEBUTAMONE; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; MIRTAZAPINE; NEFAZODONE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; VENLAFAXINE;

ADULT; ANXIETY; ARTICLE; COMORBIDITY; CONTACT PRECAUTION; DEPRESSION; DISEASE CLASSIFICATION; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; TERTIARY HEALTH CARE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; AGED; ANXIETY DISORDERS; BALTIMORE; COHORT STUDIES; CROSS INFECTION; DEPRESSIVE DISORDER; FEMALE; GLOVES, PROTECTIVE; HOSPITALS, TEACHING; HUMANS; INFECTION CONTROL; MALE; MIDDLE AGED; ODDS RATIO; PROTECTIVE CLOTHING;

EID: 80052266669     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2011.03.026     Document Type: Article

References (46)

1. Klevens R.M., Morrison M.A., Nadle J., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007, 298:1763-1771.
2. Siegel J.D., Rhinehart E., Jackson M., Chiarello L. Healthcare Infection Control Practices Advisory Committee. Management of multidrug-resistant organisms in healthcare settings 2006 2010, Centers for Disease Control and Prevention, Atlanta, GA.
3. Muto C.A., Jernigan J.A., Ostrowsky B.E., et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003, 24:362-386.
4. Morgan D.J., Diekema D.J., Sepkowitz K., Perencevich E.N. Adverse outcomes associated with contact precautions: a review of the literature. Am J Infect Control 2009, 37:85-93.
5. Illinois General Assembly Bill HB0378.
6. Kussman MJ. VHA directive 2007-002.
7. Weber S.G., Huang S.S., Oriola S., et al. Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Am J Infect Control 2007, 35:73-85.
8. Cepeda J.A., Whitehouse T., Cooper B., et al. Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study. Lancet 2005, 365:295-304.
9. Boyce J., Opal S., Chow J., et al. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994, 32:1148.
10. Morgan D.J., Liang S.Y., Smith C.L., et al. Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers. Infect Control Hosp Epidemiol 2010, 31:716-721.
11. Saint S., Higgins L.A., Nallamothu B.K., Chenoweth C. Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control 2003, 31:354-356.
12. Stelfox H.T., Bates D.W., Redelmeier D.A. Safety of patients isolated for infection control. JAMA 2003, 290:1899-1905.
13. DiMatteo M.R., Lepper H.S., Croghan T.W. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160:2101.
14. Wells K.B., Stewart A., Hays R.D., et al. The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. JAMA 1989, 262:914-919.
15. Roest A.M., Martens E.J., Denollet J., de Jonge P. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med 2010, 72:563.
16. Turner A., Phillips L., Hambridge J.A., Baker A.L., Bowman J., Colyvas K. Clinical outcomes associated with depression, anxiety and social support among cardiac rehabilitation attendees. Aust N Z J Psychiatry 2010, 44:658-666.
17. Wassenberg M., Severs D., Bonten M. Psychological impact of short-term isolation measures in hospitalised patients. J Hosp Infect 2010, 75:124-127.
18. Day H.R., Morgan D.J., Himelhoch S., Young A., Perencevich E.N. Association between depression and contact precautions in veterans at hospital admission. Am J Infect Control 2011, 39(2):163-165.
19. Zuger A. Isolation, an ancient and lonely practice, endures 31 August 2010, The New York Times, p. D5 of the New York edition.
20. Chen P.W. Losing touch with the patient 21 October 2010, The New York Times.
21. Siegel J.D., Rhinehart E., Jackson M., Chiarello L. Health Care Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007, 35(Suppl. 2):S65-S164.
22. McGregor J.C., Kim P.W., Perencevich E.N., et al. Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol 2005, 161:483-493.
23. Furuno J.P., Perencevich E.N., Johnson J.A., et al. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci co-colonization. Emerg Infect Dis 2005, 11:1539-1544.
24. Schweizer M.L., Furuno J.P., Harris A.D., et al. Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study. PloS One 2010, 5:e11432.
25. Thompson D., Hylan T.R., McMullen W., Romeis M.E., Buesching D., Oster G. Predictors of a medical-offset effect among patients receiving antidepressant therapy. Am J Psychiatry 1998, 155:824.
26. Zhang A.Y., Cooper G.S. Recognition of depression and anxiety among elderly colorectal cancer patients. Nurs Res Pract 2010, doi:10.1155/2010/693961.
27. Gedeborg R., Furebring M., Michaelsson K. Diagnosis-dependent misclassification of infections using administrative data variably affected incidence and mortality estimates in ICU patients. J Clin Epidemiol 2007, 60:155.
28. Campbell S.E., Campbell M.K., Grimshaw J.M., Walker A.E. A systematic review of discharge coding accuracy. J Public Health 2001, 23:205.
29. Thompson R.L., Cabezudo I., Wenzel R.P. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982, 97:309.
30. Garbutt J.M., Littenberg B., Evanoff B.A., Sahm D., Mundy L.M. Enteric carriage of vancomycin-resistant Enterococcus faecium in patients tested for Clostridium difficile. Infect Control Hosp Epidemiol 1999, 20:664-670.
31. Tornieporth N.G., Roberts R.B., John J., Hafner A., Riley L.W. Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis 1996, 23:767-772.
32. Magni G., De-Leo D., Schifano F. Depression in geriatric and adult medical inpatients. J Clin Psychol 1985, 41:337-344.
33. Caumo W., Schmidt A., Schneider C., et al. Risk factors for preoperative anxiety in adults. Acta Anaesthesiol Scand 2001, 45:298-307.
34. Catalano G., Houston S.H., Catalano M.C., et al. Anxiety and depression in hospitalized patients in resistant organism isolation. South Med J 2003, 96:141-145.
35. Gammon J. Analysis of the stressful effects of hospitalisation and source isolation on coping and psychological constructs. Int J Nurs Pract 1998, 4:84-96.
36. Tarzi S., Kennedy P., Stone S., Evans M. Methicillin-resistant Staphylococcus aureus: psychological impact of hospitalization and isolation in an older adult population. J Hosp Infect 2001, 49:250-254.
37. Kennedy P., Hamilton L.R. Psychological impact of the management of methicillin-resistant Staphylococcus aureus (MRSA) in patients with spinal cord injury. Spinal Cord 1997, 35:617-619.
38. Current depression among adults - United States, 2006 and 2008. Morb Mortal Wkly Rep 2010, 59:1229-1235. Centers for Disease Control and Prevention (CDC).
39. Olfson M., Shea S., Feder A., et al. Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice. Arch Fam Med 2000, 9:876-883.
40. Maguire G.P., Julier D.L., Hawton K.E., Bancroft J.H. Psychiatric morbidity and referral on two general medical wards. BMJ 1974, 1:268-270.
41. West S.L., Richter A., Melfi C.A., McNutt M., Nennstiel M.E., Mauskopf J.A. Assessing the Saskatchewan database for outcomes research studies of depression and its treatment. J Clin Epidemiol 2000, 53:823-831.
42. Holland J.C. Anxiety and cancer: the patient and the family. J Clin Psychiatry 1989, 50(Suppl.):20-25.
43. Rincon H.G., Granados M., Unutzer J., et al. Prevalence, detection and treatment of anxiety, depression, and delirium in the adult critical care unit. Psychosomatics 2001, 42:391-396.
44. Liu C.F., Campbell D.G., Chaney E.F., Li Y.F., McDonell M., Fihn S.D. Depression diagnosis and antidepressant treatment among depressed VA primary care patients. Adm Policy Ment Health Ment Health Serv Res 2006, 33:331-341.
45. Harbarth S., Fankhauser C., Schrenzel J., et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008, 299:1149-1157.
46. Robicsek A., Beaumont J.L., Paule S.M., et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008, 148:409-418.